Note 5 -. RELATED PARTY TRANSACTIONS (Details) - USD ($) |
9 Months Ended | 12 Months Ended |
|---|---|---|
Dec. 31, 2015 |
Mar. 31, 2015 |
|
| Note 5 -. Related Party Transactions Details | ||
| Balance due (to) Pharma and NDM at beginning of period | $ 192,505 | $ 0 |
| Amounts advanced to Pharma | 0 | 567,633 |
| Amounts received from Pharma | (239,717) | (7,692) |
| Reduction in prepayments to Pharma for clinical trials | (249,459) | (257,441) |
| Amounts invoiced by DDL to Pharma and NDM (sale of assets) | 17,755 | 0 |
| Amount invoiced by Pharma to DDL and TCL | (226,148) | (106,193) |
| Expenses paid by Pharma on behalf of DDL and TCL | 0 | 134 |
| Intellectual property costs paid by Pharma on behalf of DDL and TCL | 0 | (946) |
| Foreign exchange differences | 19,160 | (2,990) |
| Net balance due from (to) Pharma and NDM at end of the period | $ (485,904) | $ 192,505 |